Elos Medtech AB (publ) – Annual General Meeting 2016

The Annual General Meeting (AGM) resolved

-  Dividend for fiscal year 2015 of SEK 1.00 per share

-  The issue of warrants

-  Anders Birgersson as new member of the Board

At the AGM of Elos Medtech AB on April 26 2016, the Board’s proposal of a dividend for fiscal year 2015 of SEK 1.00 per share dividend was approved.

President Johannes Lind-Widestam provided information about the business trend during 2015 and presented the interim report for the first quarter of 2016.

The AGM resolved that the compensation payable to the Board of Directors shall be divided as follows: SEK 330,000 to the Chairman of the Board and SEK 165,000 to each Board member who is not employed by the company. Compensation amounted to total SEK 75,000 to the Remuneration Committee and the Audit Committee to be divided among the Board members as the Board’s decision.

According to previously published proposal was resolved that the Board shall have seven (7) members. The Board members Stig-Arne Blom, Agneta Bengtsson Runmarker, Jeppe Magnusson, Yvonne Mårtensson, Mats Nilsson and Thomas Öster were re-elected. Anders Birgersson was elected as new member of the Board.

Re-election of auditing company PwC (Öhrlings PricewaterhouseCoopers AB, Gothenburg) with authorized public auditor Bror Frid as senior author.

The AGM resolved to approve the Board's proposal for resolution on the issue of warrants for senior management in the Group. The decision includes a maximum of 318,473 warrants. At full subscription, the share capital will increase to about SEK 1,990,456.

Lidköping, April 27, 2016

Elos Medtech AB (publ)

For further information, contact:
Johannes Lind-Widestam, President and CEO, 46 (0)705-41 72 22, e-mail: johannes.lind-widestam@elosmedtech.com

The information in this press release is such that Elos Medtech AB is obligated to publish in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was issued for publication on 27 April 2016, at 08:00 a.m. (CET).

For additional information visit www.elosmedtech.com 


About Us

Elos Medtech is one of Europe's leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and USA. Customers are mainly internationally active medical technology companies in the market segments Dental Implant Systems, Diagnostics, Medical Devices and Trauma & Spine. Elos Medtech employs more than 500 people worldwide and generates revenue that exceeds MSEK 550. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.


Documents & Links